(Q31987923)

5 July 2017

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies (English)

1 reference

5 July 2017

0 references

F Perri

1

1 reference

5 July 2017

V Festa

2

1 reference

5 July 2017

R Clemente

3

1 reference

5 July 2017

M R Villani

4

1 reference

5 July 2017

M Quitadamo

5

1 reference

5 July 2017

N Caruso

6

1 reference

5 July 2017

M L Bergoli

7

1 reference

5 July 2017

A Andriulli

8

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

The American Journal of Gastroenterology

5 July 2017

1 reference

5 July 2017

96

1 reference

5 July 2017

1

1 reference

5 July 2017

58-62

1 reference

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

5 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Antimicrobial activity of rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Treatment of antibiotic-resistant Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Association of p53 mutations with short survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.03452.X

10.1111/J.1572-0241.2001.03452.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference